000 | 01815 a2200505 4500 | ||
---|---|---|---|
005 | 20250515060555.0 | ||
264 | 0 | _c20070820 | |
008 | 200708s 0 0 eng d | ||
022 | _a0918-6158 | ||
024 | 7 |
_a10.1248/bpb.30.460 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatanabe, Kenichi | |
245 | 0 | 0 |
_aEffects of edaravone in heart of aged rats after cerebral ischemia-reperfusion injury. _h[electronic resource] |
260 |
_bBiological & pharmaceutical bulletin _cMar 2007 |
||
300 |
_a460-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAging |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipyrine _xadministration & dosage |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBrain Ischemia _xcomplications |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aEdaravone |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 |
_aFree Radical Scavengers _xadministration & dosage |
650 | 0 | 4 |
_aGlutathione Peroxidase _xmetabolism |
650 | 0 | 4 |
_aHeart Injuries _xmetabolism |
650 | 0 | 4 |
_aIn Situ Nick-End Labeling _xmethods |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aProtein Carbonylation _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
700 | 1 | _aMa, Meilei | |
700 | 1 | _aWen, Juan | |
700 | 1 | _aKodama, Makoto | |
700 | 1 | _aAizawa, Yoshifusa | |
773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 30 _gno. 3 _gp. 460-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.30.460 _zAvailable from publisher's website |
999 |
_c16887292 _d16887292 |